-
公开(公告)号:US5919814A
公开(公告)日:1999-07-06
申请号:US66235
申请日:1998-04-24
申请人: Gerald Guillaumet , Isabelle Charton , Ahmed Mamai , Pierre Renard , Bruno Pfeiffer , Philippe Delagrange , Beatrice Guardiola
发明人: Gerald Guillaumet , Isabelle Charton , Ahmed Mamai , Pierre Renard , Bruno Pfeiffer , Philippe Delagrange , Beatrice Guardiola
IPC分类号: A61K31/335 , A61K31/35 , A61K31/352 , A61K31/357 , A61K31/38 , A61K31/382 , A61P3/04 , A61P3/08 , A61P25/00 , A61P25/04 , A61P25/18 , A61P25/20 , A61P25/28 , A61P43/00 , C07D311/04 , C07D311/64 , C07D319/18 , C07D327/06 , C07D335/06 , C07D355/04
CPC分类号: C07D335/06 , C07D311/64 , C07D319/18 , C07D327/06
摘要: The invention relates to compound of general formula (I): ##STR1## wherein: Z represents O or CH.sub.2n is from 0 to 4R, X and Y are as defined in the description, andA represents ##STR2## wherein R.sup.1, R.sup.2, R.sup.6, R.sup.7 and T' are as defined in the description,and medicinal products containing the same are useful in treating or in preventing melatoninergic disorders.
摘要翻译: 本发明涉及通式(I)的化合物:其中:Z表示O或CH 2 n为0至4 R,X和Y如说明书中所定义,A表示其中R1,R2,R6,R7和T '如说明书中所定义,含有该药物的药物可用于治疗或预防褪黑激素障碍。